For: | Popovic LS, Matovina-Brko G, Popovic M, Popovic M, Cvetanovic A, Nikolic I, Kukic B, Petrovic D. Immunotherapy in the treatment of lymphoma. World J Stem Cells 2021; 13(6): 503-520 [PMID: 34249225 DOI: 10.4252/wjsc.v13.i6.503] |
---|---|
URL: | https://www.wjgnet.com/1948-0210/full/v13/i6/503.htm |
Number | Citing Articles |
1 |
М. Р. Матущак, Г. Л. Панфілова. Pharmaceutical assessment of the rationale of the application of chemotherapy schemes containing immunotherapeutic drugs in the treatment of classical Hodgkin's lymphoma. Farmatsevtychnyi zhurnal 2023; (3): 68 doi: 10.32352/0367-3057.3.23.07
|
2 |
|
3 |
Sharina C Macapagal, Hayoung Lee, Javaria Abdul Jabbar, Anna Caroline Fjorden, Irene Tresa Joseph, Ramanpreet Kaur, Jihan A Mostafa. Efficacy of Brentuximab Vedotin and Nivolumab in Refractory or Relapsed Hodgkin Lymphoma: A Systematic Review. Cureus 2022; doi: 10.7759/cureus.23452
|